Archive for February, 2008
« Previous Entries Next Entries »FDA Strategy When Under Attack - Drift
Submitted by BioHealth Investor Blog
by Mark S. Senak
Eye On FDA
In recent weeks, policymakers have turned up the heat on the FDA. First, Congressman Bart Stupak (D-MI) sent Dr. Andrew C. von Eschenbach a Valentine by demanding his resignation on February 14. Less than a week later, Congresswoman Rosa DeLauro (D-Conn) likened the management of the [...]
Prana Biotechnology: A Challenge for the FDA
Submitted by BioHealth Investor Blog
by Michael Shulman
BiotechBlitz
Prana Biotechnology (PRAN), a tiny Australian company working for many years on a treatment for Alzheimer’s disease (AD), announced Phase II trial results yesterday that the company characterized as successful — and the stock popped 40%-50% today.
The trial results, for those who care about these things, raise many future [...]
Welcome to the eDrugSearch.com Community
Submitted by PharmaGossip Blog
SAN ANTONIO – Feb. 27, 2008 – eDrugSearch.com, the trusted search engine for Americans seeking medications from prescreened international pharmacies, has expanded its mission by unveiling the eDrugSearch.com Community, a new social network for prescription drug consumers.
“U.S. consumers who want access to prescription drugs at fair, affordable prices have long had the [...]
And the winner is…..
Submitted by PharmaGossip Blog
Diebold Accidentally Leaks Results Of 2008 Election Early
Sphere: Related Content
Rating 3.00 out of 5
[?]
Political dignity
Submitted by PharmaGossip Blog
A fleeting concept.
Hat tip: http://www.yesbutnobutyes.com/
Sphere: Related Content
Rating 3.00 out of 5
[?]
PhRMA - hey big spenders
Submitted by PharmaGossip Blog
The Pharmaceutical Research and Manufacturers of America (PhRMA) spent a total of $22,733,400 last year on Congressional lobbying activities, an increase of around 25% on 2006’s figure, according to disclosure forms posted with Congressional public records services and publicised by the Center for Responsive Politics (CRP).
PhRMA spent more on lobbying last year [...]
NICE says “no” to EPO
Submitted by PharmaGossip Blog
NICE on Monday issued yet another “no” to epoetins in cancer-induced anaemia, raising the possibility of a definitive rejection for use by the UK National Health Service (NHS) as early as April.
Sphere: Related Content
Rating 3.00 out of 5
[?]
Annuale vs Seasonale
Submitted by PharmaGossip Blog
Here’s the original!
Hat tip: http://www.pathophilia.com/
Sphere: Related Content
Rating 3.00 out of 5
[?]
Wyeth - Premarin: case enters “punitive phase”
Submitted by PharmaGossip Blog
A jury ruled in favor of a plaintiff who accused Wyeth of negligence when she got breast cancer after taking the company’s hormone-replacement therapy.
U.S. District Court jurors here yesterday ruled in favor of Donna Scroggin, who sued the Madison, N.J., company in 2004. Jurors recommended Ms. Scroggin receive $2.75 million. The punitive [...]
“Futile” anti-depressants
Submitted by PharmaGossip Blog
Prescribing anti-depressants to the vast majority of patients is futile, as the drugs have little or no impact at all, according to researchers.
Almost 50 clinical trials were reviewed by psychologists from the University of Hull who found that new-generation anti-depressants worked no better than a placebo - a dummy pill - for [...]
RX - sex and drugs and quarterly goals; Part 3
Submitted by PharmaGossip Blog
Pharmaceuticals is an ugly business. But thank God the reps are hot.
Created by Paul L. Mays and Torrance Hill.
Uh oh - Paxitram problems!
Part 4 later this week.
Sphere: Related Content
Rating 3.00 out of 5
[?]
Warning!
Submitted by PharmaGossip Blog
This site is addictive!
Sphere: Related Content
Rating 3.00 out of 5
[?]
The WSJ tour of the Wong heparin factory
Submitted by PharmaGossip Blog
Sphere: Related Content
Rating 3.00 out of 5
[?]
The WSJ tour of the Wong heparin factory
Submitted by PharmaGossip Blog
Sphere: Related Content
Rating 3.00 out of 5
[?]
Freelance
Submitted by PharmaGossip Blog
Ed has the story.
Sphere: Related Content
Rating 3.00 out of 5
[?]
France-Hypophyse - French HGH trial starts
Submitted by PharmaGossip Blog
Seven French former medical officials went on trial on Wednesday after a 17 year-long investigation into contaminated growth hormones that caused the death of more than 100 people from Creutzfeldt-Jakob disease. The doctors and pharmacists face maximum terms varying from 3 to 10 years if convicted. They face charges of aggravated deception, [...]
Roche - Xenical: UK’s toothless watchdog investigates
Submitted by PharmaGossip Blog
Big Pharma’s UK watchdog is to investigate Roche over sales tactics for its weight-loss drug Xenical to slimming clinics, the Financial Times reported.
The Prescription Medicines Code of Practice Authority’s investigation into alleged inducement and supply’ of the drug follows a formal complaint from Ryta Kuzel, former head of Roche’s UK regulatory affairs, [...]
Healthy Skepticism - news from the land down under
Submitted by PharmaGossip Blog
Australia’s finest pharma watchdog, Healthy Skepticism has been a PharmaGossip fave for some time now.
Imagine Insider’s joy when they contacted PG with some juicy news. As calls to end drug companies’ direct sponsorship of doctors’ education echo round the world, an investigation in Australia reveals sponsor involvement in the education of [...]
Monday’s Top Medical & Biotech Stocks
Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
GTX, INC. [GTXI] +36.46%
NASTECH PHARM CO [NSTK] +35.64%
GENAERA CORP [GENR] +12.72%
ZIOPHARM ONCOLOGY IN [ZIOP] +10.00%
PIPEX PHARMACEUTALS [PP] +9.80%
Diagnostic Substances
REMOTEMDX INC [RMDX.OB] +19.12%
QUIDEL CP [QDEL] +9.55%
ICAGEN, INC. [ICGN] +7.10%
MERIDIAN BIOSCIENC [...]
More Cameron Haven - Sanofi drug rep and Playboy model
Submitted by PharmaGossip Blog
Why, you ask?
Well , dear readers, you seemed to like the last post so much.
Insider saw a 50% increase in average blog traffic!
So - Insider has selflessly undertaken some “internet research” and has come up with these:
It would be rude to wake her!
What a smile!
Buns of steel
Anyone for ice cream?
Labels: [...]
Ralph Nader on Bush and the FDA
Submitted by PharmaGossip Blog
So how is the FDA doing under his watch?
A troubled agency for decades, politically undermined and deficient in budgets, the FDA is now more burdened and besieged than ever. Its budget last year was $ 2 billion–the price ten years ago of one B-2 bomber. Here are the FDA’s own words:
“More than [...]
What have these people got in common?
Submitted by PharmaGossip Blog
Woody Allen
Martin Luther King, Jr
Bill Clinton
Bruce Lee
David Duchovny
Raisa Gorbachev
Jay Leno
Harrison Ford
Steve Martin
Susan Sarandon
George Soros
Thomas Jefferson
Northrop Frye
Iris Murdoch
Alexander Solzhenitsin
Susan Sontag
Pope John Paul II
Pierre Trudeau
The Answer
Sphere: Related Content
Rating 3.00 out of 5
[?]
Is it the way you tell them?
Submitted by PharmaGossip Blog
Tyler Stillman, a psychologist at Florida State University, did a series of studies showing that laughter isn’t always about how funny something is. He found that when a boss tells a bad joke to an employee, the employee laughs. But when the employee tells a bad joke to a boss, well, you [...]
You suck at Photoshop #7
Submitted by PharmaGossip Blog
More from Donnie!
Sphere: Related Content
Rating 3.00 out of 5
[?]
Friday’s Top Medical & Biotech Stocks
Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
ONCOTHYREON [ONTY] +14.46%
NOVAVAX INC [NVAX] +9.75%
BARRIER THERAPEUTICS [BTRX] +8.61%
FAVRILLE, INC. [FVRL] +7.23%
ATHERSYS INC [ATHX] +7.14%
Diagnostic Substances
MONOGRAM BIOSCIENCES [MGRM] +4.29%
ABAXIS INC [ABAX] +3.63%
NYMOX PHARM CORP [NYMX] +3.14%
NEOGEN CP [NEOG] +1.87%
AVALON [...]
